GlassScriptPhysician profile
Anthony Rizzardi
NPI 1912261660
$1,552.30
in general payments reported to CMS, 2019-2025
25 companies · $410 in 2025
The $410 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $182 · 2021: $55.86 · 2022: $163 · 2023: $263 · 2024: $213 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $886.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $885.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $320.37 | 2020-2025 | |
| Tactile Systems Technology INC | $169.93 | 2022-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Averitas Pharma INC. | $126.96 | 2023-2025 | Qutenza |
| Boston Scientific Corporation | $126.83 | 2019-2020 | |
| Kci USA, INC. | $123.45 | 2019-2023 | Activ.A.C., Promogran Prisma |
| Smith+Nephew, INC. | $90.40 | 2020-2025 | Renasys Go V2 Home, Stravix |
| Organogenesis INC. | $87.38 | 2019-2025 | Via Matrix, Affinity |
| Stryker Corporation | $77.23 | 2019-2021 | |
| Convatec INC. | $50.29 | 2023-2025 | |
| Paratek Pharmaceuticals, INC. | $44.05 | 2024-2025 | Nuzyra |
| Solventum Corporation | $40.06 | 2024 | Activ.A.C., Promogran Prisma |
| Linvatec Corporation | $34.79 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $30.41 | 2025 | Exparel |
| Sanara Medtech INC. | $27.15 | 2022 | |
| Kerecis Limited | $25.21 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $23.45 | 2025 | Purified Cortrophin Gel |
| Osiris Therapeutics INC. | $23.29 | 2019 | |
| Djo, LLC | $21.46 | 2023 | Cmf |
| Orthofix Medical, INC. | $21.38 | 2025 | Physio-Stim |
| Depuy Synthes Sales INC. | $17.88 | 2023 | Motoband |
| Bioventus LLC | $15.50 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $14.81 | 2024 | |
| Medtronic, INC. | $14.31 | 2025 | Inceptiv |
| Kowa Pharmaceuticals America, INC. | $13.01 | 2023 | Seglentis |
| Merck Sharp & Dohme LLC | $12.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Rizzardi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.